Expertise in
8
conditions

Dr. Amy H. Case

Piedmont Providers LLC
Atlanta, GA
Expertise in
8
conditions
Specialties:Pulmonary Medicine | Intensive Care Medicine
Accepting New Patients
Offers Telehealth
Expertise in
8
conditions
OverviewInsuranceLocationsClinical Research

Overview

Amy Case is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Atlanta, Georgia. Dr. Case is highly rated in 8 conditions, according to our data. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Gastrostomy. Dr. Case is currently accepting new patients.

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Internal Medicine in GA
Hospital Affiliations
Piedmont Hospital
Piedmont Fayette Hospital
Languages Spoken
English
Bulgarian
French
Mandarin
Gender
Female

Insurance

MediFind strives to display the most accurate insurance information for every doctor. Please contact your provider to confirm if they accept your insurance.

Dr. Amy H. Case accepts the following insurance:

  •  Cigna
  •  Blue Cross Blue Shield
  •  Friday Health
  •  Alliant Health
  •  UnitedHealthcare
  •  CareSource
View 1 More Insurance +

Locations

PIEDMONT PROVIDERS LLC
1968 Peachtree Rd Nw, Atlanta, GA 30309
404-367-3210
Other Locations
PIEDMONT PROVIDERS LLC
1984 Peachtree Rd Nw, Suite 300, Atlanta, GA 30309
404-367-3210
PIEDMONT PROVIDERS LLC
275 Collier Rd Nw, Suite 300, Atlanta, GA 30309
404-350-0009
PIEDMONT PROVIDERS LLC
1968 Peachtree Nw Rd, Atlanta, GA 30309
404-605-5000
PIEDMONT PROVIDERS LLC
3820 Medical Park Dr, Austell, GA 30106
770-948-6041

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
Pulmonary Fibrosis Foundation Patient Registry
Pulmonary Fibrosis Foundation Patient Registry
Enrollment Status: Completed
Publish Date: July 07, 2023
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Enrollment Status: Completed
Publish Date: February 15, 2021
Intervention Type: Other
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

16 Total Publications

Persistence of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Pulmonary Fibrosis Foundation Patient Registry Study.
Persistence of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Pulmonary Fibrosis Foundation Patient Registry Study.
Journal: Annals of the American Thoracic Society
Published: October 15, 2024
Similar Doctors
Expertise in
16
conditions
Dr. Srihari Veeraraghavan
Pulmonary Medicine | Intensive Care Medicine
Expertise in
16
conditions
Dr. Srihari Veeraraghavan
Pulmonary Medicine | Intensive Care Medicine

The Emory Clinic Inc

1365 Clifton Rd Ne, 
Atlanta, GA 
 4.5 mi
Accepting New Patients
Languages Spoken English, Tamil

Srihari Veeraraghavan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Atlanta, Georgia. Dr. Veeraraghavan is highly rated in 16 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Sarcoidosis, and Lung Transplant. Dr. Veeraraghavan is currently accepting new patients.

Expertise in
7
conditions
Dr. Vibha N. Lama
Pulmonary Medicine | Intensive Care Medicine
Expertise in
7
conditions
Dr. Vibha N. Lama
Pulmonary Medicine | Intensive Care Medicine

The Emory Clinic Inc

1365 Clifton Rd Ne, 
Atlanta, GA 
 4.5 mi
Accepting New Patients
Languages Spoken English, Hindi

Vibha Lama is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Atlanta, Georgia. Dr. Lama is highly rated in 7 conditions, according to our data. Her top areas of expertise are Bronchiolitis Obliterans, Bronchitis, Pulmonary Fibrosis, Acute Interstitial Pneumonia, and Lung Transplant. Dr. Lama is currently accepting new patients.

Expertise in
17
conditions
Dr. David M. Berkowitz
Pulmonary Medicine | Intensive Care Medicine
Expertise in
17
conditions
Dr. David M. Berkowitz
Pulmonary Medicine | Intensive Care Medicine

The Emory Clinic Inc

1365 Clifton Rd Ne, 
Atlanta, GA 
 4.5 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

David Berkowitz is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Atlanta, Georgia. Dr. Berkowitz is highly rated in 17 conditions, according to our data. His top areas of expertise are Lymphofollicular Hyperplasia, Lung Cancer, Pleural Effusion, Gastrostomy, and Advanced Bronchoscopy. Dr. Berkowitz is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile